The human intestinal microbiome substantially affects human health and resistance to
infections in its dynamic composition and varying release of microbial-derived metabolites …

Gut microbiota can interact with the immune system through its metabolites. Short-chain fatty
acids (SCFAs), as one of the most abundant metabolites of the resident gut microbiota play …

Background & Aims Recent studies have highlighted the role of the gut microbiota and their
metabolites in non-alcoholic fatty liver disease-associated hepatocellular carcinoma …

Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a wide
spectrum of liver injuries, ranging from hepatic steatosis, metabolic dysfunction-associated …

“Dietary fiber”(DF) refers to a type of carbohydrate that cannot be digested fully. DF is not an
essential nutrient, but it plays an important part in enhancing digestive capacity and …

Tumor immune microenvironment (TIME), a tumor-derived immune component, is proven to
be closely related to the development, metastasis, and recurrence of tumors. Gut microbiota …

Accumulating evidence indicates an alarming increase in the incidence of early-onset
cancers, which are diagnosed among adults under 50 years of age, in the colorectum …

The gut microbiota and Short-chain fatty acids (SCFAs) can influence the progression of
diseases, yet the role of these factors on gastric cancer (GC) remains uncertain. In this work …

The multiple beneficial effects of the short-chain fatty acid (SCFA) butyrate on human health,
produced from fermentable carbohydrates by gut microbiota in the colon, are well known. At …

Hepatobiliary malignancies, which include hepatocellular carcinoma (HCC) and
cholangiocarcinoma (CCA), are the sixth most common cancers and the third leading cause …